Defining Current Patterns of Blood Product Use during Intensive Induction Chemotherapy in Newly Diagnosed Acute Myeloid Leukemia Patients

por Miller, Liron, Freed-Freundlich, Mor, Shimoni, Avichai, Hellou, Tamer, Avigdor, Abraham, Misgav, Mudi, Canaani, Jonathan
Publicado 2023

Nsaids Linked to IgA-Mediated Hypersensitivity Vasculitis and Purpura Fulminans-Like Eruption

por Levenberg, Guy, Bleier, Jonathan, Leibowitz, Avshalom, Salomon, Ophira, Misgav, Mudi, Agmon-Levin, Nancy, Shavit, Ronen
Publicado 2023

Turoctocog alfa pegol (N8‐GP) in severe hemophilia A: Long‐term safety and efficacy in previously treated patients of all ages in the pathfinder8 study

por Lentz, Steven R., Kavakli, Kaan, Klamroth, Robert, Misgav, Mudi, Nagao, Azusa, Tosetto, Alberto, Jørgensen, Pernille Juul, Zak, Marek, Nemes, Laszlo
Publicado 2022

Real-World Data on Bleeding Patterns of Hemophilia A Patients Treated with Emicizumab

por Levy-Mendelovich, Sarina, Brutman-Barazani, Tami, Budnik, Ivan, Avishai, Einat, Barg, Assaf A., Levy, Tamara, Misgav, Mudi, Livnat, Tami, Kenet, Gili
Publicado 2021

Cardiac surgery in patients with Hemophilia:is it safe?

por Shalabi, Amjad, Kachel, Erez, Kogan, Alexander, Sternik, Leonid, Grosman-Rimon, Liza, Ben-Avi, Ronny, Ghanem, Diab, Ram, Eyalon, Raanani, Ehud, Misgav, Mudi
Publicado 2020

Correction to: Cardiac surgery in patients with Hemophilia:is it safe?

por Shalabi, Amjad, Kachel, Erez, Kogan, Alexander, Sternik, Leonid, Grosman-Rimon, Liza, Ben-Avi, Ronny, Ghanem, Diab, Ram, Eilon, Raanani, Ehud, Misgav, Mudi
Publicado 2020

Once‐weekly prophylaxis with glycoPEGylated recombinant factor VIII (N8‐GP) in severe haemophilia A: Safety and efficacy results from pathfinder 2 (randomized phase III trial)

por Curry, Nicola, Albayrak, Canan, Escobar, Miguel, Andre Holme, Pål, Kearney, Susan, Klamroth, Robert, Misgav, Mudi, Négrier, Claude, Wheeler, Allison, Santagostino, Elena, Shima, Midori, Landorph, Andrea, Tønder, Sidsel Marie, Lentz, Steven R.
Publicado 2019

Management of surgery in persons with hemophilia A receiving emicizumab prophylaxis: data from a national hemophilia treatment center

por Cohen, Omri, Levy-Mendelovich, Sarina, Budnik, Ivan, Ludan, Noa, Lyskov, Shani Kassia, Livnat, Tami, Avishai, Einat, Efros, Orly, Lubetsky, Aharon, Lalezari, Shadan, Misgav, Mudi, Brutman-Barazani, Tami, Kenet, Gili, Barg, Assaf A.
Publicado 2023